Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Apixaban Is Effective and Safe in Reducing Venous Thromboembolism (VTE) in Obese Patients with Newly Diagnosed Pediatric Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma (ALL/LL) a Sub-Study Analysis of the Prevapix-ALL/Children's Oncology Group ACCL1333 Trial

Vilmarie Rodriguez, Sarah O'Brien, Glen Lew, Etan Orgel, Kimberly Derr, Mark A. Ranalli, Corinna L. Schultz, Adam J. Esbenshade, Arteid Memaj, Joshua Dyme, Nicholas Favatella, Lesley Mitchell

Blood (2023) 142 (Supplement 1): 810.

https://doi.org/10.1182/blood-2023-180037

Published: 2023

Journal Articles

The ELEMENT-MDS Trial: A Phase 3 Randomized Study Evaluating Luspatercept Versus Epoetin Alfa in Erythropoiesis-Stimulating Agent-Naive, Non-Transfusion-Dependent, Lower-Risk Myelodysplastic Syndromes

Amer M. Zeidan, Rami S. Komrokji, Rena Buckstein, Valeria Santini, Shelonitda Rose, Priya Malini, Glen Lew, Dimple Aggarwal, Karen L. Keeperman, Huijing Jiang, Ana Carolina Giuseppi, Jennie Zhang, Thomas Cluzeau, Jake Shortt, Uwe Platzbecker

Blood (2023) 142 (Supplement 1): 6503.

https://doi.org/10.1182/blood-2023-178635

Published: 2023

Journal Articles

Poverty during Maintenance and Relapse Risk in Children with Acute Lymphoblastic Leukemia (ALL): A Report from Children's Oncology Group Study (COG-AALL03N1)

Aman Wadhwa, Yanjun Chen, Lindsey Hageman, Anna Hoppmann, Anne L Angiolillo, David Dickens, Glen Lew, Joseph P. Neglia, Yaddanapudi Ravindranath, Arthur K. Ritchey, Amanda Muench Termuhlen, Lennie Wong, Wendy Landier, Smita Bhatia

Blood (2022) 140 (Supplement 1): 2183–2184.

https://doi.org/10.1182/blood-2022-163271

Published: 2022

Journal Articles

Redefining Hyperviscosity in Acute Leukemia: Implications for Red Cell Transfusions

Jamie Oakley, Evelyn Kendall Williams, Dan Y. Zhang, Christina Caruso, Yumiko Sakurai, Reginald Tran, Melissa L. Kemp, Glen Lew, Ross M. Fasano, Wilbur A. Lam

Blood (2021) 138 (Supplement 1): 3253.

https://doi.org/10.1182/blood-2021-146577

Published: 2021

Journal Articles

Does Body Mass Index (BMI) during Maintenance Influence Relapse Risk in Children with Acute Lymphoblastic Leukemia (ALL)? Results from COG-AALL03N1

Blood (2021) 138 (Supplement 1): 213.

https://doi.org/10.1182/blood-2021-148121

Published: 2021

Journal Articles

Premedication and Longer Infusion Time Do Not Reduce the Incidence of Hypersensitivity Reactions to Pegaspargase

Catherine Hughes, PharmD, Valeria Bernardo, PharmD, Susanne Youssef, PharmD, James P. Hughes, PhD, Frank G. Keller, MD, Tamara P. Miller, MDMSc, Sharon M. Castellino, MD MSc, Glen Lew, MD

Blood (2020) 136 (Supplement 1): 4–5.

https://doi.org/10.1182/blood-2020-143248

Published: 2020

Journal Articles

Incorporating Hemoglobin Levels to Map Leukostasis Risk in Acute Leukemia Using Microvasculature-on-Chip Technologies

Jamie Oakley, MD, Evelyn K. Williams, BS, Christina Caruso, MD, Yumiko Sakurai, MSc, Reginald Tran, PhD, Glen Lew, MD, Wilbur A. Lam, MDPhD

Blood (2020) 136 (Supplement 1): 9–10.

https://doi.org/10.1182/blood-2020-137804

Published: 2020

Journal Articles

Absence of Silent Inactivation Using Intravenous Pegaspargase in Pediatric Acute Lymphoblastic Leukemia

Sarayu Kumar, BA, BSPH, Curtis D Travers, MPH, John Bergsagel, MD, Frank G Keller, MD, Melinda Pauly, MD, Himalee Sabnis, MDMS, Sharon M. Castellino, MD MSc, Glen Lew, MD

Blood (2017) 130 (Supplement 1): 100.

https://doi.org/10.1182/blood.V130.Suppl_1.100.100

Published: 2017

Journal Articles

Outcomes after Intermediate-Risk Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL) and the Role of Allogeneic Stem Cell Transplantation (SCT): A Report from Children's Oncology Group (COG) AALL0433

Glen Lew, MD, Xiaomin Lu, PhD, Rochelle Yanofsky, MD FRCP(C), Susan R. Rheingold, MD, James Whitlock, Qi An, Meenakshi Devidas, PhD, Caroline A. Hastings, MD, Naomi J. Winick, MD, William L. Carroll, MD, Michael J. Borowitz, MD PhD, Stephen Hunger, MD, Michael A. Pulsipher, MD

Blood (2014) 124 (21): 684.

https://doi.org/10.1182/blood.V124.21.684.684

Published: 2014

Journal Articles

Impact of 6 Mercaptopurine (6MP) Pill-Taking Habits on Adherence, Thioguanine Nucleotide (TGN) Levels and Relapse Risk in Children with Acute Lymphoblastic Leukemia (ALL): Results from a Children’s Oncology Group (COG) Study (AALL03N1)

Lindsey Hageman, Wendy Landier, PhD, R.N., Yanjun Chen, MS, Heeyoung Kim, M.S., Nancy Kornegay, M.S., William E. Evans, PharmD, Bruce C. Bostrom, MD, Jacqueline Casillas, MD, M.S.H.S., David Dickens, MD, Anne Angiolillo, MD, Glen Lew, MD, Kelly Maloney, MD, Leo Mascarenhas, Arthur K. Ritchey, MD, Amanda Termuhlen, MD, William L. Carroll, MD, Mary V. Relling, PharmD, F. Lennie Wong, Smita Bhatia, PhD

Blood (2014) 124 (21): 369.

https://doi.org/10.1182/blood.V124.21.369.369

Published: 2014

Journal Articles

“Russell-like” bodies in Philadelphia chromosome–positive B-lymphoblastic leukemia

Silvia T. Bunting, Glen Lew

Blood (2014) 123 (16): 2448.

https://doi.org/10.1182/blood-2014-01-547513

Published: 2014

Journal Articles

High Intra-Individual Variability In Systemic Exposure To 6 Mercaptopurine (6MP) In Children With Acute Lymphoblastic Leukemia (ALL) Contributes To ALL Relapse: Results From a Children’s Oncology Group (COG) Study (AALL03N1)

Smita Bhatia, Ph.D., Wendy Landier, Ph.D., R.N., Lindsey Hageman, Can-Lan Sun, Heeyoung Kim, M.S., Nancy Kornegay, M.S., William E. Evans, PharmD, Bruce C. Bostrom, MD, Jacqueline Casillas, M.D., M.S.H.S, Anne Angiolillo, MD, Glen Lew, MD, Kelly Maloney, MD, Leo Mascarenhas, Jane Meza, Ph.D., A. Kim Ritchey, MD, Amanda Termuhlen, MD, William L. Carroll, MD, F. Lennie Wong, PhD, Mary V. Relling, PharmD

Blood (2013) 122 (21): 59.

https://doi.org/10.1182/blood.V122.21.59.59

Published: 2013

Journal Articles

Genome-Wide Association Analyses Identify Susceptibility Loci For Vincristine-Induced Peripheral Neuropathy In Children With Acute Lymphoblastic Leukemia

Blood (2013) 122 (21): 618.

https://doi.org/10.1182/blood.V122.21.618.618

Published: 2013

Journal Articles

Acute Neurotoxicity In Children with Acute Lymphoblastic Leukemia: An Association with Day-36 Intrathecal Methotrexate In Delayed Intensification

Jennifer C. Andrews, MD, John Bergsagel, MD, Glen Lew, MD

Blood (2010) 116 (21): 3224.

https://doi.org/10.1182/blood.V116.21.3224.3224

Published: 2010

Journal Articles

Targeting CD22 in Childhood B-Precursor Acute Lymphoblastic Leukemia (Pre-B ALL): Pre-Clinical Studies and Phase I Trial of the Anti-CD22 Immunotoxin CAT-3888 (BL22).

Alan S. Wayne, MD, Harry W. Findley, PhD, Glen Lew, MD, Yachna Ahuja, BS, Lubing Gu, MD, Maryalice Stetler-Stevenson, MD, PhD, Robert J. Kreitman, MD, Ira Pastan, MD

Blood (2007) 110 (11): 855.

https://doi.org/10.1182/blood.V110.11.855.855

Published: 2007

Journal Articles

Pediatric Acute Biphenotypic Leukemia (aBL): A Clinico-Pathologic Analysis of a Single Institution Experience.

Hal E. Crosswell, MD, Robert B. Yost, MD, Carol N. Phillips, MS, Jeannine Holden, MD, Michael Briones, DO, Bergsagel J. Daniel, MD, William G. Woods, MD, Glen Lew, MD

Blood (2005) 106 (11): 4480.

https://doi.org/10.1182/blood.V106.11.4480.4480

Published: 2005

NARROW

Apixaban Is Effective and Safe in Reducing Venous Thromboembolism (VTE) in Obese Patients with Newly Diagnosed Pediatric Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma (ALL/LL) a Sub-Study Analysis of the Prevapix-ALL/Children's Oncology Group ACCL1333 Trial

The ELEMENT-MDS Trial: A Phase 3 Randomized Study Evaluating Luspatercept Versus Epoetin Alfa in Erythropoiesis-Stimulating Agent-Naive, Non-Transfusion-Dependent, Lower-Risk Myelodysplastic Syndromes

Poverty during Maintenance and Relapse Risk in Children with Acute Lymphoblastic Leukemia (ALL): A Report from Children's Oncology Group Study (COG-AALL03N1)

Redefining Hyperviscosity in Acute Leukemia: Implications for Red Cell Transfusions

Does Body Mass Index (BMI) during Maintenance Influence Relapse Risk in Children with Acute Lymphoblastic Leukemia (ALL)? Results from COG-AALL03N1

Premedication and Longer Infusion Time Do Not Reduce the Incidence of Hypersensitivity Reactions to Pegaspargase

Incorporating Hemoglobin Levels to Map Leukostasis Risk in Acute Leukemia Using Microvasculature-on-Chip Technologies

Absence of Silent Inactivation Using Intravenous Pegaspargase in Pediatric Acute Lymphoblastic Leukemia

Outcomes after Intermediate-Risk Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL) and the Role of Allogeneic Stem Cell Transplantation (SCT): A Report from Children's Oncology Group (COG) AALL0433

Impact of 6 Mercaptopurine (6MP) Pill-Taking Habits on Adherence, Thioguanine Nucleotide (TGN) Levels and Relapse Risk in Children with Acute Lymphoblastic Leukemia (ALL): Results from a Children’s Oncology Group (COG) Study (AALL03N1)

“Russell-like” bodies in Philadelphia chromosome–positive B-lymphoblastic leukemia

High Intra-Individual Variability In Systemic Exposure To 6 Mercaptopurine (6MP) In Children With Acute Lymphoblastic Leukemia (ALL) Contributes To ALL Relapse: Results From a Children’s Oncology Group (COG) Study (AALL03N1)

Genome-Wide Association Analyses Identify Susceptibility Loci For Vincristine-Induced Peripheral Neuropathy In Children With Acute Lymphoblastic Leukemia

Acute Neurotoxicity In Children with Acute Lymphoblastic Leukemia: An Association with Day-36 Intrathecal Methotrexate In Delayed Intensification

Targeting CD22 in Childhood B-Precursor Acute Lymphoblastic Leukemia (Pre-B ALL): Pre-Clinical Studies and Phase I Trial of the Anti-CD22 Immunotoxin CAT-3888 (BL22).

Pediatric Acute Biphenotypic Leukemia (aBL): A Clinico-Pathologic Analysis of a Single Institution Experience.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only